InspireMD, Inc.
NSPR
$1.18
$0.043.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.57% | 39.39% | 2.24% | 1.19% | 10.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.57% | 39.39% | 2.24% | 1.19% | 10.68% |
| Cost of Revenue | 33.04% | 18.84% | 4.05% | 1.48% | 17.83% |
| Gross Profit | 151.60% | 108.70% | -5.44% | 0.00% | -7.13% |
| SG&A Expenses | 59.35% | 107.22% | 83.01% | 51.41% | 43.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.61% | 51.62% | 47.98% | 45.54% | 49.50% |
| Operating Income | -29.01% | -54.23% | -57.62% | -54.57% | -61.28% |
| Income Before Tax | -28.34% | -61.06% | -66.28% | -58.79% | -70.69% |
| Income Tax Expenses | 6.78% | -- | -- | -- | -9.23% |
| Earnings from Continuing Operations | -28.20% | -61.06% | -66.28% | -58.79% | -69.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.20% | -61.06% | -66.28% | -58.79% | -69.73% |
| EBIT | -29.01% | -54.23% | -57.62% | -54.57% | -61.28% |
| EBITDA | -28.51% | -53.99% | -57.58% | -54.69% | -61.68% |
| EPS Basic | 23.88% | -6.07% | -16.97% | -8.71% | -16.74% |
| Normalized Basic EPS | 23.78% | -6.08% | -16.98% | -8.81% | -17.32% |
| EPS Diluted | 23.88% | -6.07% | -16.97% | -8.71% | -16.74% |
| Normalized Diluted EPS | 23.78% | -6.08% | -16.98% | -8.81% | -17.32% |
| Average Basic Shares Outstanding | 68.48% | 51.89% | 42.16% | 46.00% | 45.39% |
| Average Diluted Shares Outstanding | 68.48% | 51.89% | 42.16% | 46.00% | 45.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |